In a world where health and well-being are paramount, dietary supplements sales have continued to increase and are expected to grow with a CAGR of 9.0% from 2023 to 2030. The reason for the growth most likely stems from increased consumer interest moving away from pharmaceuticals as well as an increased interest in personalized nutrition. Yet, given this growth, the dietary supplement user demographics are limited at best. The more educated and more affluent a consumer is, the more likely they are to use supplements. Women, asian, and non-hispanic white adults are the most common users. Hispanic and non-Hispanic black adults, not so much. Along the same lines, there has been increased attention being paid to the issue of the lack of diversity in clinical trials. This is critical as many drugs and supplements may have different effects on different ethnic groups and different genders. Bridging the gap in clinical trials may be an important first step to creating a more inclusive and safe dietary supplement industry. 

Empowering Diversity for Reliable Insights

The stark reality stands out: despite constituting only 30% of the U.S. population, Caucasian males have overwhelmingly dominate clinical trials. This troubling lack of representation goes beyond a mere statistic; it casts a significant disparity for the broader population, especially those historically marginalized. Black individuals, women, and other underrepresented groups find themselves sidelined, their unique experiences and health needs often disregarded in clinical research.

This imbalance not only undermines the credibility of the findings but perpetuates health disparities, leaving marginalized communities behind. The implications ripple into the sphere of dietary supplements, magnifying the significance of comprehensive and inclusive clinical trials. If these trials predominantly feature one demographic, how can we ensure that dietary supplements are equally safe and effective for everyone, regardless of their race, gender, or background? The lack of diversity is exacerbated when it comes to gaps in regulations. While certain ingredients may be deemed “safe,” how can we confidently assert that a supplement is safe for a Black woman when her representation in clinical trials has been limited?

Addressing these dual challenges is no longer optional—it’s an ethical and practical imperative, not to mention it just makes good business sense. The call for equitable representation and rigorous safety evaluations in the dietary supplement landscape isn’t just about regulatory compliance; it’s about recognizing the humanity and health needs of every individual, irrespective of their background or identity. Why cater to 30% of the population, when you can authentically expand your potential customer base by embracing diversity, equity, and inclusion? It’s about fostering a healthier and more equitable future for all, where the promises of dietary supplements are accessible to everyone and tailoring your science, clinical trials, and marketing accordingly.

This is why bridging these gaps is pivotal for the future of dietary supplements and the well-being of diverse populations. By striving for inclusivity, transparency, and a dedication to sound scientific practice, we can pave the way for a healthier, safer, and more informed future—one where dietary supplement enhances well-being for all, regardless of background or origin. It’s a win for science, consumers, and the bottom line. 

Did you like it?
Share it with friends!